1. Dramatic improvement in non-AIDS related progressive multifocal leucoencephalopathy. Issue 9 (16th August 2005) Authors: Auré, K; Béhin, A; Louillet, F; Lafitte, C; Sanson, M; Vernant, J P Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 76:Issue 9(2005) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI). (9th September 2021) Authors: Ducray, F; Sanson, M; Chinot, O; Fontanilles, M; Rivoirard, R; Thomas-Maisonneuve, L; Cartalat, S; Tabouret, E; Bonneville-Levard, A; Darlix, A; Ameli, R; Meyronet, D; Gueyffier, F; Remontet, L; Maucort-Boulch, D; Dehais, C; Honnorat, J Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS05.2.A MGMT promoter status in IDH1/2 mutant anaplastic astrocytoma patients assessed by DNA methylation profiling and qMS-PCR: a report from the EORTC Brain Tumor Group. (9th September 2021) Authors: Tesileanu, C M S; French, P J; Sanson, M; Brandes, A A; Wick, W; Clement, P M; Kros, J M; Gorlia, T; Golfinopoulos, V; van den Bent, M J Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS07.1.A A threshold of mitotic activity and post-surgery residual volume are independant prognostic factors in astrocytoma IDH-mutant. (5th September 2022) Authors: Tran, S; Thomas, A; Touat, M; Karachi, C; Lozano, F; Mokhtari, K; Dehais, C; Feuvret, L; Carpentier, C; Giry, M; Doukani, H; Lerond, J; Marie, Y; Sanson, M; Idbaih, A; Carpentier, A; Hoang-Xuan, K; Capelle, L; Bielle, F Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS4.3 Feasibility and benefit of Molecular Profiling to Guide Enrollment of Patients with Recurrent Gliomas in Early Phase Trials. (6th September 2019) Authors: Baldini, C; Younan, N; Castanon Alvarez, E; Bahleda, R; Hollebecque, A; Dhermain, F; Ammari, S; Alentorn, A; Dumont, S; Frenel, J; Di Stefano, A; Bielle, F; Hoang-Xuan, K; Delattre, J; Soria, J; Sanson, M; Idbaih, A; Massard, C; Touat, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience. (6th September 2019) Authors: GRAILLON, T; Colin, T; Peyrière, H; Peyre, M; Tabouret, E; Campello, C; Idbaih, A; Boucekine, M; Figarella-Branger, D; Kalamarides, M; Dufour, H; Sanson, M; Chinot, O Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion. (6th September 2019) Authors: Picca, A; Alentorn, A; Saragoussi, E; Bielle, F; Ducray, F; Villa, C; Schmitt, Y; Lerond, J; Leclerc, J; Lasorella, A; Iavarone, A; Mokhtari, K; Savatovsky, J; Sanson, M; Di Stefano, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OS9.7 Telomere length, TERTp mutation and ALT status in adult diffuse gliomas. (6th September 2019) Authors: Birzu, C; Hillairet, A; Giry, M; Grandin, N; Verrelle, P; Mokhtari, K; Marie, Y; Hoang-Xuan, K; Delattre, J; Idbaih, A; Charbonneau, M; Sanson, M; Alentorn, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study. (19th September 2018) Authors: Alentorn, A; Labreche, K; Dehais, C; Carpentier, C; Ducray, F; Mokhtari, K; Figarella-Branger, D; Sanson, M; Delattre, J; Idbaih, A Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators. (6th September 2019) Authors: Berzero, G; Di Stefano, A; Ronchi, S; Villa, C; Marie, Y; Hoang-Xuan, K; Delattre, J; Mokhtari, K; Sanson, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗